The BioTexas Cafe will host THBI's signature educational events. These discussions bring together THBI members, policy leaders, legislative staff and key agencies for insightful conversations. BioTexas Cafe will invite expert speakers to cover a wide array of topics from the current global health pandemic to latest developments and policy issues impacting the life sciences in Texas. 

During this the time of limited travel and social interaction, all BioTexas Cafe events will be presented as online webinars and conference calls. In the future, we expect to hold these events online and in-person throughout the state.

To learn more about sponsoring or participating in the BioTexas Cafe, email Julia Perkins.


Stay tuned for upcoming event details.


BioTexas Cafe - Value in Innovation, Driving Patient Outcomes Through Scientific Advancements

Sponsored by Genentech, Novartis and Vertex
December 1, 2020

Join us for a policy discussion on the value of innovative genomic therapies, diagnostics and treatments, and alternative payment models. THBI's Policy Director Meredith Armstrong will lead this important conversation with guest speakers Tricia Fitzsimmons, Executive Director, Public Policy, Novartis, Scott McGoohan, JD, Senior Director, Government Affairs and Public Policy, Vertex Pharmaceuticals, and Casey O'Neill, Principal, Genentech.

Register to Attend

THBI President's Call with Special Guest, Mike Mattoon

This month's special guest Mike Mattoon, Vice President of Federal Government Relations at Biotechnology Innovation Organization (BIO) joins us for a federal update as we head into the election. Mike shared with members what he is seeing as we are now one week away from very important federal elections, and shared an outlook on how the different outcomes could effect the life sciences industry. 

THBI President's Calls are member-only events. To learn how to access these events, email 

BioTexas Cafe - The Promise of Personalized Medicine: CAR T-Cell Therapy

Sponsored by Bristol Myers Squibb
October 15, 2020

Special guest Dr. Michele Sharr McMahon, Director, Global Drug Development at Bristol Myers Squibb shares the work of her and her team on Novel cell-based therapies, such as CAR T, that use a person’s own cells are unlocking new potential in the fight against some of the most difficult-to-treat cancers.  As a company on the forefront of scientific innovation, Bristol Myers Squibb is evaluating new and next-generation cell therapies and investing in technology to ensure that our health care system continues to support the development and access for these personalized treatments for patients today, and for the future. 

How CAR T Works

THBI President's Call with Special Guest, Elliott Francis

Tom Kowalski, THBI's President and CEO,  speaks with Elliott M. Francis, Director of Diversity and Inclusion at Biotechnology Innovation Organization (BIO). Elliott shares insight on his leadership role to drive change through the development and implementation of strategic diversity and inclusion initiatives in the biotechnology and life sciences industry, and within BIO. 

View Recorded Webinar

BioTexas Cafe - A Discussion on COVID-19 Vaccines and Therapeutics 
Co-Hosted by Texas Association of Manufacturers 

In partnership with Texas Association of Manufacturers (TAM), Tom Kowalski, President and CEO of THBI, Tony Bennett, President and CEO of TAM, and our member companies provide an update on COVID-19 vaccines and therapeutics and how companies produce and distribute these products.

Listen to Recorded Webinar

The Latest on COVID-19, A Town Hall Discussion
Sponsored by Amgen

This BioTexas Cafe featured speakers providing an update on the impact of COVID-19 and the latest efforts from the state and life sciences industry.  Guest speakers included Texas State Representative Oscar Longoria (HD 35), Vice Chair of the House Appropriations Committee, on the impact of COVID-19 on the Texas economy and state budget; Amy Walker, Director of Infectious Diseases Policy for Biotechnology Innovation Organization (BIO) for an update on the biopharmaceutical industry and their member's efforts on COVID-19 vaccine and therapeutic development; and Elliott M. Levy, M.D., Senior Vice President of Research & Development Strategy & Operations at Amgen on the company's COVID-19 research and development progress. 

View Recorded Webinar
Download BIO Presentation Slides

THBI President's Call with Special Guest Wayne Roberts

Tom Kowalski, THBI's President and CEO,  speaks with Wayne Roberts, CEO of the Cancer Prevention and Research Institute of Texas (CPRIT). The discussion is focused on the impact of CPRIT, and how COVID-19 has effected CPRIT and the upcoming granting process.  Mr. Roberts also gives his forecast for the upcoming legislative session, with insight on the state budget. 

View Recorded Webinar

THBI President's Call with Special Guests Tony Mitchell and Scott Newkirk

Meredith Armstrong, THBI's Policy Director, speaks with guests Tony Mitchell from CSL Behring and Scott Newkirk from CSL Plasma. The discussion focuses on the work CSL Behring is doing during COVID-19 and the importance of plasma donation.

View Recorded Webinar

THBI President's Call with Special Guest Emma Schwartz

Tom Kowalski, THBI's President and CEO,  speaks with Emma Schwartz, President of the Medical Center of the Americas (MCA) Foundation. The discussion is focused on BIO El Paso-Juarez’s COVID-19 response, including ramping up critical PPE, as well as medical supply and device production on US-Mexico Border.

View Recorded Webinar
View City of El Paso's Press Release

COVID-19 and the Important Role of Manufacturing

This discussion, lead by THBI and the Texas Association of Manufacturers (TAM), focused on the strength of the manufacturing industry during the pandemic and provide an overview of the important work Texas companies are doing to combat COVID-19.

Featured speakers:
- Tom Kowalski, President and CEO of THBI
- Tony Bennett, President and CEO of TAM
- Clement Lewin, Associate Vice President Head BARDA Office and NV Stakeholder Engagement at Sanofi
- Jeffrey Wade, Executive Vice President, Corporate and Administrative Affairs and CFO at Lexicon Pharmaceuticals

View Recorded Webinar

COVID-19 and the Importance of Policy on Public Health

This presentation was focused on the importance of public policy in fighting public health crises. 
Dr. Rodney Rohde, Professor and Chair for the Clinical Laboratory Science (CLS) Program in the College of Health Professions at Texas State University and Tom Kowalski, CEO of THBI discuss best practices policy leaders can learn from COVID-19 and how to be better prepared for the next virus. 

View Recorded Webinar

THBI COVID-19 Webinar with Texas Biomedical Research Institute

Hear the latest COVID-19 research and development efforts being conducted at the Texas Biomedical Research Institute campus in San Antonio.  Dr. Larry Schlesinger, CEO and Dr. Joanne Turner, Vice President for Research will discuss the Institute’s unique role in the bioscience landscape and how its team of researchers are tackling the newest threat – COVID-19 – followed by a Q&A!

View Presentation PDF
View Recorded Webinar